New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Cleveland, Ohio
Edgell
1989
|
| Schriftenreihe: | Neurology
39,11, Suppl. 2 |
| Schlagworte: | |
| Beschreibung: | 106 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV004144783 | ||
| 003 | DE-604 | ||
| 005 | 20150625 | ||
| 007 | t | ||
| 008 | 901115s1989 ad|| |||| 10||| eng d | ||
| 035 | |a (OCoLC)231102011 | ||
| 035 | |a (DE-599)BVBBV004144783 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-19 | ||
| 245 | 1 | 0 | |a New strategies in dopaminergic therapy of Parkinson's disease |b the use of a controlled-release formulation |c Roger C. Duvoisin suppl. ed. |
| 264 | 1 | |a Cleveland, Ohio |b Edgell |c 1989 | |
| 300 | |a 106 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Neurology |v 39,11, Suppl. 2 | |
| 650 | 0 | 7 | |a Kontrollierte Wirkstofffreisetzung |0 (DE-588)4165181-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a L-Dopa |0 (DE-588)4114371-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1989 |z London |2 gnd-content | |
| 689 | 0 | 0 | |a Parkinson-Krankheit |0 (DE-588)4044683-9 |D s |
| 689 | 0 | 1 | |a L-Dopa |0 (DE-588)4114371-1 |D s |
| 689 | 0 | 2 | |a Kontrollierte Wirkstofffreisetzung |0 (DE-588)4165181-9 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Duvoisin, Roger C. |d 1927- |e Sonstige |0 (DE-588)172051053 |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-002586083 | ||
Datensatz im Suchindex
| _version_ | 1804118359246110720 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)172051053 |
| building | Verbundindex |
| bvnumber | BV004144783 |
| ctrlnum | (OCoLC)231102011 (DE-599)BVBBV004144783 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01318nam a2200349 cb4500</leader><controlfield tag="001">BV004144783</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20150625 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">901115s1989 ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231102011</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004144783</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New strategies in dopaminergic therapy of Parkinson's disease</subfield><subfield code="b">the use of a controlled-release formulation</subfield><subfield code="c">Roger C. Duvoisin suppl. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cleveland, Ohio</subfield><subfield code="b">Edgell</subfield><subfield code="c">1989</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">106 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Neurology</subfield><subfield code="v">39,11, Suppl. 2</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kontrollierte Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4165181-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">L-Dopa</subfield><subfield code="0">(DE-588)4114371-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1989</subfield><subfield code="z">London</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Parkinson-Krankheit</subfield><subfield code="0">(DE-588)4044683-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">L-Dopa</subfield><subfield code="0">(DE-588)4114371-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Kontrollierte Wirkstofffreisetzung</subfield><subfield code="0">(DE-588)4165181-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Duvoisin, Roger C.</subfield><subfield code="d">1927-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)172051053</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002586083</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1989 London gnd-content |
| genre_facet | Konferenzschrift 1989 London |
| id | DE-604.BV004144783 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T16:09:02Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002586083 |
| oclc_num | 231102011 |
| open_access_boolean | |
| owner | DE-12 DE-19 DE-BY-UBM |
| owner_facet | DE-12 DE-19 DE-BY-UBM |
| physical | 106 S. Ill., graph. Darst. |
| publishDate | 1989 |
| publishDateSearch | 1989 |
| publishDateSort | 1989 |
| publisher | Edgell |
| record_format | marc |
| series2 | Neurology |
| spelling | New strategies in dopaminergic therapy of Parkinson's disease the use of a controlled-release formulation Roger C. Duvoisin suppl. ed. Cleveland, Ohio Edgell 1989 106 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Neurology 39,11, Suppl. 2 Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 gnd rswk-swf Parkinson-Krankheit (DE-588)4044683-9 gnd rswk-swf L-Dopa (DE-588)4114371-1 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1989 London gnd-content Parkinson-Krankheit (DE-588)4044683-9 s L-Dopa (DE-588)4114371-1 s Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 s DE-604 Duvoisin, Roger C. 1927- Sonstige (DE-588)172051053 oth |
| spellingShingle | New strategies in dopaminergic therapy of Parkinson's disease the use of a controlled-release formulation Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd L-Dopa (DE-588)4114371-1 gnd |
| subject_GND | (DE-588)4165181-9 (DE-588)4044683-9 (DE-588)4114371-1 (DE-588)1071861417 |
| title | New strategies in dopaminergic therapy of Parkinson's disease the use of a controlled-release formulation |
| title_auth | New strategies in dopaminergic therapy of Parkinson's disease the use of a controlled-release formulation |
| title_exact_search | New strategies in dopaminergic therapy of Parkinson's disease the use of a controlled-release formulation |
| title_full | New strategies in dopaminergic therapy of Parkinson's disease the use of a controlled-release formulation Roger C. Duvoisin suppl. ed. |
| title_fullStr | New strategies in dopaminergic therapy of Parkinson's disease the use of a controlled-release formulation Roger C. Duvoisin suppl. ed. |
| title_full_unstemmed | New strategies in dopaminergic therapy of Parkinson's disease the use of a controlled-release formulation Roger C. Duvoisin suppl. ed. |
| title_short | New strategies in dopaminergic therapy of Parkinson's disease |
| title_sort | new strategies in dopaminergic therapy of parkinson s disease the use of a controlled release formulation |
| title_sub | the use of a controlled-release formulation |
| topic | Kontrollierte Wirkstofffreisetzung (DE-588)4165181-9 gnd Parkinson-Krankheit (DE-588)4044683-9 gnd L-Dopa (DE-588)4114371-1 gnd |
| topic_facet | Kontrollierte Wirkstofffreisetzung Parkinson-Krankheit L-Dopa Konferenzschrift 1989 London |
| work_keys_str_mv | AT duvoisinrogerc newstrategiesindopaminergictherapyofparkinsonsdiseasetheuseofacontrolledreleaseformulation |